vs
百利高（PRGO）与UWM Holdings Corp（UWMC）财务数据对比。点击上方公司名可切换其他公司
百利高的季度营收约是UWM Holdings Corp的1.2倍（$1.1B vs $945.2M），UWM Holdings Corp净利率更高（2.1% vs -127.8%，领先129.9%），UWM Holdings Corp同比增速更快（68.7% vs -2.5%），百利高自由现金流更多（$148.6M vs $82.0M），过去两年UWM Holdings Corp的营收复合增速更高（28.8% vs 1.3%）
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
UWM控股（前身为联合海岸金融服务）是总部位于美国密歇根州庞蒂亚克的批发抵押贷款机构，专门为独立贷款经纪人提供贷款承销服务，据2024年公开数据显示，该公司是目前美国规模最大的抵押贷款放贷机构。
PRGO vs UWMC — 直观对比
营收规模更大
PRGO
是对方的1.2倍
$945.2M
营收增速更快
UWMC
高出71.3%
-2.5%
净利率更高
UWMC
高出129.9%
-127.8%
自由现金流更多
PRGO
多$66.6M
$82.0M
两年增速更快
UWMC
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $945.2M |
| 净利润 | $-1.4B | $19.4M |
| 毛利率 | 32.6% | — |
| 营业利润率 | -116.0% | 17.9% |
| 净利率 | -127.8% | 2.1% |
| 营收同比 | -2.5% | 68.7% |
| 净利润同比 | -3093.9% | 117.6% |
| 每股收益（稀释后） | $-10.23 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRGOUWMC
| Q4 25 | $1.1B | $945.2M | ||
| Q3 25 | $1.0B | $843.3M | ||
| Q2 25 | $1.1B | $758.7M | ||
| Q1 25 | $1.0B | $613.4M | ||
| Q4 24 | $1.1B | $560.2M | ||
| Q3 24 | $1.1B | $526.4M | ||
| Q2 24 | $1.1B | $507.1M | ||
| Q1 24 | $1.1B | $570.0M |
净利润PRGOUWMC
| Q4 25 | $-1.4B | $19.4M | ||
| Q3 25 | $7.5M | $-1.3M | ||
| Q2 25 | $-8.4M | $22.9M | ||
| Q1 25 | $-6.4M | $-13.7M | ||
| Q4 24 | $-44.4M | $8.9M | ||
| Q3 24 | $-21.0M | $-6.3M | ||
| Q2 24 | $-108.4M | $3.0M | ||
| Q1 24 | $2.0M | $8.7M |
毛利率PRGOUWMC
| Q4 25 | 32.6% | — | ||
| Q3 25 | 36.1% | — | ||
| Q2 25 | 34.4% | — | ||
| Q1 25 | 37.6% | — | ||
| Q4 24 | 33.9% | — | ||
| Q3 24 | 37.2% | — | ||
| Q2 24 | 37.0% | — | ||
| Q1 24 | 33.1% | — |
营业利润率PRGOUWMC
| Q4 25 | -116.0% | 17.9% | ||
| Q3 25 | 7.0% | 1.5% | ||
| Q2 25 | 4.3% | 43.4% | ||
| Q1 25 | 4.5% | -42.5% | ||
| Q4 24 | 10.0% | 7.6% | ||
| Q3 24 | 7.4% | 6.1% | ||
| Q2 24 | -2.5% | 15.2% | ||
| Q1 24 | -5.1% | 32.3% |
净利率PRGOUWMC
| Q4 25 | -127.8% | 2.1% | ||
| Q3 25 | 0.7% | -0.1% | ||
| Q2 25 | -0.8% | 3.0% | ||
| Q1 25 | -0.6% | -2.2% | ||
| Q4 24 | -3.9% | 1.6% | ||
| Q3 24 | -1.9% | -1.2% | ||
| Q2 24 | -10.2% | 0.6% | ||
| Q1 24 | 0.2% | 1.5% |
每股收益（稀释后）PRGOUWMC
| Q4 25 | $-10.23 | $0.14 | ||
| Q3 25 | $0.05 | $-0.01 | ||
| Q2 25 | $-0.06 | $0.11 | ||
| Q1 25 | $-0.05 | $-0.12 | ||
| Q4 24 | $-0.32 | $0.07 | ||
| Q3 24 | $-0.15 | $-0.06 | ||
| Q2 24 | $-0.79 | $0.03 | ||
| Q1 24 | $0.01 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $503.4M |
| 总债务越低越好 | — | $3.0B |
| 股东权益账面价值 | $2.9B | $1.6B |
| 总资产 | $8.5B | $16.9B |
| 负债/权益比越低杠杆越低 | — | 1.87× |
8季度趋势，按日历期对齐
现金及短期投资PRGOUWMC
| Q4 25 | — | $503.4M | ||
| Q3 25 | $432.1M | $870.7M | ||
| Q2 25 | $454.2M | $490.0M | ||
| Q1 25 | $409.9M | $485.0M | ||
| Q4 24 | $558.8M | $507.3M | ||
| Q3 24 | $1.5B | $636.3M | ||
| Q2 24 | $542.8M | $680.2M | ||
| Q1 24 | $658.5M | $605.6M |
总债务PRGOUWMC
| Q4 25 | — | $3.0B | ||
| Q3 25 | — | $3.8B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.0B |
股东权益PRGOUWMC
| Q4 25 | $2.9B | $1.6B | ||
| Q3 25 | $4.4B | $1.6B | ||
| Q2 25 | $4.5B | $1.7B | ||
| Q1 25 | $4.4B | $1.6B | ||
| Q4 24 | $4.3B | $2.1B | ||
| Q3 24 | $4.6B | $2.2B | ||
| Q2 24 | $4.5B | $2.3B | ||
| Q1 24 | $4.7B | $2.5B |
总资产PRGOUWMC
| Q4 25 | $8.5B | $16.9B | ||
| Q3 25 | $10.1B | $17.0B | ||
| Q2 25 | $10.1B | $13.9B | ||
| Q1 25 | $9.8B | $14.0B | ||
| Q4 24 | $9.6B | $15.7B | ||
| Q3 24 | $11.2B | $15.1B | ||
| Q2 24 | $10.4B | $12.9B | ||
| Q1 24 | $10.6B | $12.8B |
负债/权益比PRGOUWMC
| Q4 25 | — | 1.87× | ||
| Q3 25 | — | 2.38× | ||
| Q2 25 | — | 1.59× | ||
| Q1 25 | — | 1.70× | ||
| Q4 24 | — | 1.36× | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | — | 0.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $175.4M | $103.8M |
| 自由现金流经营现金流 - 资本支出 | $148.6M | $82.0M |
| 自由现金流率自由现金流/营收 | 13.4% | 8.7% |
| 资本支出强度资本支出/营收 | 2.4% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 5.34× |
| 过去12个月自由现金流最近4个季度 | $145.1M | $-2.7B |
8季度趋势，按日历期对齐
经营现金流PRGOUWMC
| Q4 25 | $175.4M | $103.8M | ||
| Q3 25 | $51.7M | $-3.1B | ||
| Q2 25 | $75.9M | $-265.9M | ||
| Q1 25 | $-64.5M | $593.9M | ||
| Q4 24 | $312.6M | $-543.3M | ||
| Q3 24 | $42.2M | $-2.2B | ||
| Q2 24 | $9.5M | $-1.3B | ||
| Q1 24 | $-1.4M | $-2.2B |
自由现金流PRGOUWMC
| Q4 25 | $148.6M | $82.0M | ||
| Q3 25 | $29.8M | $-3.1B | ||
| Q2 25 | $56.7M | $-290.1M | ||
| Q1 25 | $-90.0M | $576.1M | ||
| Q4 24 | $274.9M | $-551.6M | ||
| Q3 24 | $15.1M | $-2.2B | ||
| Q2 24 | $-18.9M | $-1.3B | ||
| Q1 24 | $-26.5M | $-2.2B |
自由现金流率PRGOUWMC
| Q4 25 | 13.4% | 8.7% | ||
| Q3 25 | 2.9% | -366.4% | ||
| Q2 25 | 5.4% | -38.2% | ||
| Q1 25 | -8.6% | 93.9% | ||
| Q4 24 | 24.2% | -98.5% | ||
| Q3 24 | 1.4% | -416.1% | ||
| Q2 24 | -1.8% | -262.1% | ||
| Q1 24 | -2.4% | -387.7% |
资本支出强度PRGOUWMC
| Q4 25 | 2.4% | 2.3% | ||
| Q3 25 | 2.1% | 1.2% | ||
| Q2 25 | 1.8% | 3.2% | ||
| Q1 25 | 2.4% | 2.9% | ||
| Q4 24 | 3.3% | 1.5% | ||
| Q3 24 | 2.5% | 2.3% | ||
| Q2 24 | 2.7% | 2.4% | ||
| Q1 24 | 2.3% | 1.2% |
现金转化率PRGOUWMC
| Q4 25 | — | 5.34× | ||
| Q3 25 | 6.89× | — | ||
| Q2 25 | — | -11.61× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -60.91× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -431.86× | ||
| Q1 24 | -0.70× | -252.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
UWMC
暂无分部数据
